tiprankstipranks
Trending News
More News >
ABVC BioPharma, Inc. (ABVC)
NASDAQ:ABVC
US Market

ABVC BioPharma (ABVC) Income Statement

Compare
124 Followers

ABVC BioPharma Income Statement

Last quarter (Q3 2025), ABVC BioPharma's total revenue was $795.95K, an increase of 104.47% from the same quarter last year. In Q3, ABVC BioPharma's net income was $-1.25M. See ABVC BioPharma’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Dec 24Dec 23Dec 22Dec 21Dec 20
Total Revenue
$ 509.59K$ 152.43K$ 969.78K$ 355.80K$ 483.05K
Gross Profit
$ 508.83K$ -149.61K$ 683.37K$ 350.71K$ 464.33K
Operating Expenses
$ 5.21M$ 6.62M$ 15.80M$ 12.06M$ 8.97M
Depreciation and Amortization
$ 200.92K$ 380.39K$ 23.80K$ 11.99K$ 37.14K
EBITDA
$ -4.34M$ -6.33M$ -15.20M$ -10.97M$ -10.37M
Operating Income
$ -4.71M$ -6.77M$ -15.11M$ -11.71M$ -8.51M
Other Income/Expenses
$ -664.33K$ -1.26M$ -400.18K$ 495.14K$ -2.31M
Pretax Income
$ -5.37M$ -8.02M$ -15.51M$ -11.21M$ -10.81M
Net Income
$ -4.90M$ -7.79M$ -16.42M$ -12.84M$ -9.79M
Per Share Metrics
Basic EPS
$ -0.42$ -1.80$ -5.20$ -5.10$ -5.00
Diluted EPS
$ -0.42$ -1.80$ -5.20$ -5.10$ -5.00
Weighted Average Shares Outstanding
11.67M 4.34M 3.17M 2.51M 1.97M
Weighted Average Shares Outstanding (Diluted)
11.67M 4.34M 3.17M 2.51M 1.97M
Currency in USD

ABVC BioPharma Earnings and Revenue History